91 related articles for article (PubMed ID: 1255745)
1. Antigenic cross-reactivity between adenocarcinoma of the breast and fibrocystic disease of the breast.
Avis F; Avis I; Newsome JF; Haughton G
J Natl Cancer Inst; 1976 Jan; 56(1):17-25. PubMed ID: 1255745
[TBL] [Abstract][Full Text] [Related]
2. Antigenic cross-reactivity between benign and malignant neoplasms of the human breast.
Avis F; Mosonov I; Haughton G
J Natl Cancer Inst; 1974 Apr; 52(4):1041-9. PubMed ID: 4826577
[No Abstract] [Full Text] [Related]
3. Simultaneous assays of cancer associated antigens in benign and malignant breast diseases.
Franchimont P; Zangerle PF; Hendrick JC; Reuter A; Colin C
Cancer; 1977 Jun; 39(6 Suppl):2806-12. PubMed ID: 68808
[No Abstract] [Full Text] [Related]
4. Humoral immunologic response in patients with tumors of the breast.
Glazman H; Salwa J; Harlozińska A
Arch Immunol Ther Exp (Warsz); 1973; 21(1):175-84. PubMed ID: 4720430
[No Abstract] [Full Text] [Related]
5. Mediation of cytotoxic immune responses against human tumor-associated antigens by allogeneic immune RNA.
Kern DH; Fritze D; Schick PM; Chow N; Pilch YH
J Natl Cancer Inst; 1976 Jul; 57(1):105-9. PubMed ID: 1003493
[TBL] [Abstract][Full Text] [Related]
6. Certain aspects of analysis of complement dependent antibody in breast cancer patients.
Hindsley JP; Avis I; Newsome JF; Fried FA; Avis FP
J Surg Oncol; 1979; 11(2):107-27. PubMed ID: 439897
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of leukocyte migration by human breast-cancer-associated antigens.
Kadish AS; Marcus DM; Bloom BR
Int J Cancer; 1976 Nov; 18(5):581-6. PubMed ID: 62721
[TBL] [Abstract][Full Text] [Related]
8. Cell-mediated immunity to tumor antigens in patients with renal cell carcinoma.
Cummings KB; Peter JB; Kaufman JJ
J Urol; 1973 Jul; 110(1):31-5. PubMed ID: 4713354
[No Abstract] [Full Text] [Related]
9. Immunological studies of women with primary breast carcinoma.
Jeejeebhoy HF
Int J Cancer; 1975 Jun; 15(6):867-78. PubMed ID: 1150343
[TBL] [Abstract][Full Text] [Related]
10. Relationship of human natural lymphocyte-mediated cytotoxicity to cytotoxicity of breast-cancer-derived target cells.
Cannon GB; Bonnard GD; Djeu J; West WH; Herberman RB
Int J Cancer; 1977 Apr; 19(4):487-97. PubMed ID: 844917
[TBL] [Abstract][Full Text] [Related]
11. Antigenic cross reactivity between benign prostatic hyperplasia and adenocarcinoma of prostate.
Avis F; Avis I; Cole AT; Fried F; Haughton G
Urology; 1975 Jan; 5(1):122-30. PubMed ID: 1114533
[TBL] [Abstract][Full Text] [Related]
12. Problems in the clinical use of the microcytotoxicity assay for measuring cell-mediated immunity to tumor cells.
Heppner G; Henry E; Stolbach L; Cummings F; McDonough E; Calabresi P
Cancer Res; 1975 Aug; 35(8):1931-7. PubMed ID: 1149017
[TBL] [Abstract][Full Text] [Related]
13. Surface antigen(s) common to human astrocytoma cells.
Coakham H
Nature; 1974 Jul; 250(464):328-30. PubMed ID: 4859513
[No Abstract] [Full Text] [Related]
14. Immunologic evaluation of human renal cell carcinoma. In vitro studies.
Elhilali MM; Nayak SK
Invest Urol; 1975 Jul; 13(1):60-6. PubMed ID: 49333
[TBL] [Abstract][Full Text] [Related]
15. Lymphocytotoxicity to tumor target cells and interference of serum factors or tumor antigen with lymphocytotoxicity in patients suffering from different stages of breast carcinoma.
Warnatz H; Lackner D; Eder E; Scheiffarth F; Gruhl M; Bischoff O
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976 Feb; 85(2):181-94. PubMed ID: 130746
[TBL] [Abstract][Full Text] [Related]
16. Cellular immune reaction to human malignant melanoma and breast carcinoma cells.
Canevari S; Fossati G; Della Porta G
J Natl Cancer Inst; 1976 Apr; 56(4):705-9. PubMed ID: 1255793
[TBL] [Abstract][Full Text] [Related]
17. Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors.
Kufe D; Inghirami G; Abe M; Hayes D; Justi-Wheeler H; Schlom J
Hybridoma; 1984; 3(3):223-32. PubMed ID: 6094338
[TBL] [Abstract][Full Text] [Related]
18. Immunocytochemical reactivity of a mouse monoclonal antibody CDI 315B raised against human breast carcinoma.
Beketić-Oresković L; Sarcević B; Malenica B; Novak D
Neoplasma; 1993; 40(2):69-74. PubMed ID: 8394515
[TBL] [Abstract][Full Text] [Related]
19. Isoantigens A, B and H in benign and malignant lesions of breast.
Gupta RK; Schuster R
Am J Pathol; 1973 Aug; 72(2):253-7. PubMed ID: 4807589
[TBL] [Abstract][Full Text] [Related]
20. In vitro detection of cytotoxic cellular immunity against tumor-specific antigens by a radioisotopic technique.
Jagarlamoody SM; Aust JC; Tew RH; McKhann CF
Proc Natl Acad Sci U S A; 1971 Jun; 68(6):1346-50. PubMed ID: 4331089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
